Geometry.Net - Basic

MEDLINEplus: COPD (Chronic Obstructive Pulmonary Disease)
Breathing. Latest News Genetic Risks of emphysema Pinpointed in Mice (03/12/2003,Reuters Health). General Prevent emphysema Now! Advice for
http://www.nlm.nih.gov/medlineplus/copdchronicobstructivepulmonarydisease.html
Clinical Alert: NHLBI-Funded Emphysema Study Finds Certain Patients At High Risk
Clinical Alert NHLBIFunded emphysema Study Finds Certain Patientsat High Risk for Death Following Lung Surgery. National Heart
http://www.nlm.nih.gov/databases/alerts/emphysema.html

Extractions: Emphysema patients who have severe lung obstruction with either limited ability to exchange gas when breathing or damage that is evenly distributed throughout their lungs receive little benefit from lung volume reduction surgery (LVRS) and are at high risk of death from the procedure, according to early results from the National Emphysema Treatment Trial (NETT). NETT is a five-year, multicenter, randomized study to evaluate the role of LVRS in the treatment of severe emphysema. This is the first time that researchers have identified scientifically based selection criteria for patients seeking LVRS as a potential treatment for advanced emphysema. As a result of the findings, patients with these high-risk characteristics are no longer being enrolled in NETT; however, the study will continue to recruit other eligible patients until its scheduled completion in 2002. "This is exactly the kind of insight we hope to gain from NETT," said Dr. Claude Lenfant, director of the National Heart, Lung, and Blood Institute (NHLBI), the primary sponsor of the study. "Identifying which patients should not undergo this surgery is a key goal of this study. We expect the final results of NETT will guide us further in determining if and when this procedure should be used to treat emphysema."
Alpha1-Antitrypsin Deficiency Of Inherited Emphysema-Medfacts-National Jewish Me
Definition, diagnosis, and treatment for inherited emphysema.Category Health Conditions and Diseases emphysemaAlpha1Antitrypsin Deficiency of Inherited emphysema and Management MedFact fromNational Jewish Medical and Research Center 1 Respiratory Hospital in America.
http://www.nationaljewish.org/medfacts/alpha1.html

Extractions: Chronic obstructive pulmonary disease or COPD for short, is a lung disease that affects millions of people each year. COPD is a general term used to describe diseases such as emphysema and chronic bronchitis. In emphysema there is damage to the walls of the air sacs (alveoli) in the lungs. Most cases of emphysema are caused by smoking or other environmental factors. However, in a small number of cases of emphysema, there is a hereditary basis for the disease. The earliest symptom of emphysema is shortness of breath during activity. Later the shortness of breath occurs with rest also. The inherited form of emphysema is called alpha1 antitrypsin deficiency or "alpha - one" for short. People with this disease don't have enough of a major protein in the blood. This protein is alpha1 antitrypsin. Although there are many different genetic variations of this protein, only some will cause lung disease. It is more often seen in people of northern European descent, especially Scandinavians. What Does the Alpha1 Protein do in the Body?
RESOURCES FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASES (COPD)(E.G., Emphysema, Chr
Resources for Chronic Obstructive Pulmonary Diseases (COPD) (EG, emphysema, ChronicBronchitis)Med Fact From National Jewish Medical and Research Center 1
http://www.nationaljewish.org/medfacts/resources.html

Extractions: (E.G., Emphysema, Chronic Bronchitis) The Chronic Bronchitis and Emphysema Handbook by Francois Haas and Sheila Sperber Haas. New York: Wiley, 1990. ISBN 0-471-62263-X. (New edition due in 1999) Enjoying Life with Chronic Obstructive Pulmonary Disease by Thomas L. Petty and Louise M. Nett. 3rd ed. Cedar Grove, NJ: Laennec Pub. Inc., 1995. ISBN 1-886128-04-9. Seven Steps to a Smoke-Free Life Shortness of Breath: A Guide to Better Living and Breathing by Andrew L. Ries and Kenneth L. Moser. 5th ed. St. Louis, Mo.: Mosby, 1996. ISBN 0-8151-7339-3. Travel for the Patient with Chronic Obstructive Pulmonary Disease by Harold M. Silver and Myra Feldman. 2nd Bethesda, MD 20817: Harold M. Silver, 8029 Herb Farm Drive, 1995. Good if not Great Travel with Oxygen: Experiences, Equipment Usage and Easy by Phil Petersen. Charlotte, NC: Raven Publishers, 1996. ISBN 0-9621726-3-4. by Jean Gomez. Albuquerque, NM 87122: Jean Gomez, 9304 Oakland NE, 1996. Understanding Emphysema and Chronic Bronchitis (standard and easy to read versions). National Jewish Medical and Research Center, 1998.
Pulmonary Pathology
The chest cavity is opened at autopsy to reveal numerous large bullae apparent onthe surface of the lungs in a patient dying with emphysema.Bullae are large
http://medlib.med.utah.edu/WebPath/LUNGHTML/LUNG056.html

Extractions: The chest cavity is opened at autopsy to reveal numerous large bullae apparent on the surface of the lungs in a patient dying with emphysema.Bullae are large dilated airspaces that bulge out from beneath the pleura.Emphysema is characterized by a loss of lung parenchyma by destruction of alveoli so that there is permanent dilation of airspaces.
Emphysema Center
Information about therapy for emphysema and lung volume reduction and pulmonary rehabilitation program.Category Health Conditions and DiseasesCOPDemphysema Center. Division of reduction surgery. Therapy for emphysema/LungVolume Reduction. The Pulmonary Rehabilitation Program.
http://www.chestsurg.org/emphsema.htm

Extractions: In response to the recent developments in the fields of volume reduction surgery and lung transplantation, a Multidisciplinary Clinic has been established for the evaluation and care of patients with surgically treatable emphysema and chronic obstructive pulmonary disease. In addition, an Emphysema Cooperative Study Group has been established consisting of community and academic pulmonologists and thoracic surgeons throughout New England. Activities are centered around a prospective randomized trial seeking to compare the efficacy of pulmonary rehabilitation alone in emphysema patients eligible for volume reduction surgery versus rehabilitation of these patients followed by volume reduction surgery. Therapy for Emphysema/Lung Volume Reduction The Pulmonary Rehabilitation Program var MenuLinkedBy='AllWebMenus [2]', awmBN='460'; awmAltUrl=''; var MenuLinkedBy='AllWebMenus [2]', awmBN='460'; awmAltUrl=''; var MenuLinkedBy='AllWebMenus [2]', awmBN='460'; awmAltUrl='';
Emphysema
A look at the causes, symptoms, and treatment for emphysema.Category Health Conditions and Diseases emphysemaemphysema. . emphysema Abnormal of lungs. emphysema is the most commoncause of death from respiratory disease in the United States.
http://www.med-help.com/Emphysema.html

Extractions: Emphysema: Abnormal irreversible enlargement of air spaces distal to terminal bronchioles caused by destruction of alveolar walls, resulting in decreased elastic recoil properties of lungs. Emphysema is the most common cause of death from respiratory disease in the United States. Cause: Cigarette smoking, deficiency of alpha,-antitrypsin. Recurrent inflammation associated with release of proteolytic enzymes from lung cells causes bronchiolar and alveolar wall damage and, ultimately, destruction. Loss of lung supporting structure results in decreased elastic recoil and airway collapse on expiration. Destruction of alveolar walls decreases surface area for gas exchange. Symptoms: Dyspnea (labored or difficulty breathing) Chronic cough Anorexia Weight loss Malaise Barrel chest Use of accessory muscles of respiration Prolonged expiratory period with grunting Pursed - lip breathing Tachypnea (rapid respiration) Complications includes: recurrent respiratory tract infections, cor pulmonale, and respiratory failure Treatment: Bronchodilators - to promote mucociliary clearance Antibiotics to treat respiratory infection; Influenza vaccine to prevent influenza; and Pneumococcal vaccine to prevent pneumococcal pneumonia
Ask Dr Stoll
An article about emphysema patients pulmonary function improving by very gentle rebounding.Category Health Conditions and Diseases emphysemaThis page has moved to http//askwaltstollmd.com/rebounding.html.You should be automatically redirected there within 5 seconds.
http://bcn.net/~stoll/rebounding.html
Emphysema And Lung Cancer Treatment And Surgery, COPD, Breathing Disorders And B
A look at the diseases treated and the surgical procedures for lung cancer and emphysema. Abstracts Category Health Conditions and Diseasesemphysema, Lung Cancer, Chronic Obstructive Pulmonary Disease COPDand other breathing disorders. emphysema, Lung Cancer, Chronic
http://www.cmclungctr.com/

Extractions: Emphysema, Lung Cancer, Chronic Obstructive Pulmonary Disease [COPD] and other breathing disorders. Emphysema, Lung Cancer, Chronic Obstructive Pulmonary Disease [COPD] and other breathing disorders and difficulties are what we treat in a caring atmosphere here at the Chapman Lung Center. We are your specialists in treating lung cancer and emphysema. Featuring new surgical procedures that may improve the quality of life for many patients with severe emphysema and a minimally invasive surgery for lung cancer, the Chapman Lung Center continues to strive to be at the forefront of the medical community. Video Assisted Thoracoscopic Surgery (VATS) for Lung Volume Reduction Surgery Lung Volume Reduction Surgery (LVRS) is an effective new treatment in properly selected patients with moderate to severe symptoms from emphysema. Over the past several years, numerous papers have demonstrated the benefits of LVRS in thousands of patients. For most patients, LVRS improved pulmonary function tests, relieved oxygen and steriod dependence, relieved symptoms of dyspnea and improved quality of life, with reasonable morbidity and mortality. In contrast, medical management, including pulmonary rehabilitation, has failed to improve pulmonary function tests despite decreasing oxygen requirements and increasing exercise tolerance.
Department Of Veterans' Affairs -
Information on chronic bronchitis and/or emphysema and death from chronic bronchitis and/or emphysema.Category Health Conditions and Diseases Determination. of. Statement of Principles concerning CHRONIC BRONCHITISAND emphysema ICD CODES 491, 492 Veterans' Entitlements Act 1986. 1
http://www.dva.gov.au/pensions/statemnt/h001bp.htm

Extractions: Veterans' Entitlements Act 1986 The Repatriation Medical Authority under subsection of the Veterans' Entitlements Act 1986 (the Act): (a) revokes Instrument No.137 of 1996 (Statement of Principles concerning chronic airflow limitation); and (b) determines in its place the following Statement of Principles. Kind of injury, disease or death . (a) This Statement of principles is about chronic bronchitis and/or emphysema and death from chronic bronchitis and/or emphysema. (b) For the purposes of this Statement of Principles, (i) "chronic bronchitis" means a respiratory tract disorder characterised by excessive mucus production sufficient to cause cough and sputum production with expectoration for at least three months of each of at least two consecutive years which is not attributable to other respiratory diseases, attracting ICD code 491. The bronchitis may be be present alone or may be accompanied by chronic airways obstruction or limitation, with or without a reversible component. There are four categories of chronic bronchitis: chronic simple bronchitis, chronic mucopurulent bronchitis, asthmatic bronchitis and chronic bronchitis with pulmonary obstruction. This definition specifically excludes bronchiolitis and chronic obstruction from bronchiolitis;
HON - News : A Gene For Emphysema Is Discovered
Other news for emphysema Hereditary Diseases. A Gene for emphysema Is DiscoveredIts absence leads to the lung disease, mouse study proves
http://www.hon.ch/News/HSN/512176.html

Extractions: HealthScoutNews Reporter WEDNESDAY, March 12 (HealthScoutNews) In one of the more complicated biomedical research stories you will encounter this year, scientists at the University of California at San Francisco have identified a gene that can increase susceptibility to the crippling lung disease emphysema. Dr. David G. Morris, an assistant professor of medicine at the university and leader of the group reporting the finding in the March 13 issue of Nature , can explain it all to you in about 10 minutes, if you are willing to follow a tangled tale of genes, enzymes and proteins. And although the research was done with mice, it might lead to better treatment of emphysema in humans. The gene in question is one whose activity affects growth factor-beta (TGF-beta), which is already known to be involved in one lung disease, fibrosis, that involves the growth of unwanted tissue in the lungs. Emphysema is a completely different condition, in which there is slow degradation of lung tissue, specifically the alveoli, the tiny air sacs through which oxygen flows. The alveoli become abnormally enlarged and lose elasticity because of the steady destruction of a vital structural protein, elastin. Emphysema is known to be caused by smoking. However, genetics also plays a role, because most people who smoke for decades do not develop the disease only 10 percent to 15 percent do. One genetic defect has already been identified, an absence of alpha-1 antitrypsin, which protects against the destruction of elastin.
The Scientist :: Emphysema's Smoking Gun
emphysema's smoking gun. TGFß regulates the enzyme that mediates thepathology of emphysema. By Richard Robinson. Long-term cigarette
http://www.biomedcentral.com/news/20030313/05/

Extractions: Long-term cigarette smoking is a leading cause of pulmonary emphysema, in which loss of elasticity in lung tissue leads to alveolar enlargement and coalescence, and impaired gas exchange. Extracellular proteases , which help control that elasticity, have been implicated in the development of emphysema, but how these enzymes are regulated has been unclear. In the March 13 Nature , Dean Sheppard and colleagues at the University of California, San Francisco Nature 422:169-173, March 13, 2003). Links for this article
Emphysema
Information about emphysema. What causes it, symptoms and the statistics.Category Health Conditions and Diseases emphysema What is emphysema? emphysema is a condition in which there is overinflationof structures in the lungs known as alveoli or air sacs.
http://www.mamashealth.com/emphy.asp

Extractions: What is Emphysema? Emphysema is a condition in which there is over-inflation of structures in the lungs known as alveoli or air sacs. This over-inflation results from a breakdown of the walls of the alveoli, which causes a decrease in respiratory function and breathlessness. In Emphysema, the lungs loose elasticity and are unable to fully expand and contract. This occurs because the air sacs cannot completely deflate, thus unable to fill with fresh air for adequate ventilation. Emphysema in children is usually caused by congenital abnormalities of the lung and alpha-1 antitrypsin deficiency. In emphysema, the patient can breathe in but breating out is difficult and inefficient. The seriousness of emphysema varies greatly. Some persons never reach a stage of incapacity and go through life with relatively litte inconvenience, while in others, the disease worsens until final degeneration of the ability to breath occurs.
Ontario Lung Association: Your Lungs: Emphysema
Your Lungs What is emphysema? With emphysema, the smallest airways and the airsacs themselves are damaged and inflamed. emphysema is a serious disease.
http://www.on.lung.ca/yourlungs/emphysema.html

Extractions: With emphysema, the smallest airways and the air sacs themselves are damaged and inflamed. Associated with this inflammation is swelling which narrows the airways making the flow of air difficult. There is a loss of elasticity of the lung tissue which normally holds the airways open. This loss of elasticity contributes to the narrowing of the airways. Did you know... Emphysema is a serious disease. When the bronchi are damaged by cigarette smoke, the walls of the tiny air spaces and blood vessels may be destroyed. As the walls of the air spaces are damaged, the whole lung may get larger. A patient with emphysema may not be able to walk or climb stairs without an oxygen tank. As the disease gets worse, the heart must work harder to pump blood. The heart may get larger because of the strain. Finally, it will give out.
Protein Crucial For Elastic Fiber Developement Described By UCSD Schol Of Medici
fiber in the body. In addition, this loss can lead to some forms ofchronic lung disease, such as emphysema. Now, new findings by
http://health.ucsd.edu/news/2002/01_09_Nakamura.html

Extractions: Described by UCSD School of Medicine Researchers Sagging skin and stiff, twisted arteries are considered a natural, if unfortunate, aspect of growing old that is caused by loss of elastic fiber in the body. In addition, this loss can lead to some forms of chronic lung disease, such as emphysema. Now, new findings by researchers at the University of California, San Diego (UCSD) School of Medicine offer insight into the role of a recently discovered protein in the development of elastic fibers, and the potential for future therapies to combat these and other aspects of aging. In a paper published in the January 10, 2002 issue of the journal Nature , investigators in the UCSD Institute of Molecular Medicine (IMM) describe the crucial role of a protein called fibulin-5, or DANCE (Developing Arteries and Neural Crest EGF-like), in the generation and organization of elastic fibers in mice. Tomoyuki Nakamura, M.D., Ph.D.
Emphysema - University Of Maryland Thoracic Surgery Division
Thoracic Surgery Division. emphysema. According to the American Lung Association,approximately 2.0 million Americans are living with emphysema today.
http://www.umm.edu/thoracic/thoracic4.html

Extractions: Thoracic Surgery Division Emphysema (a type of Chronic Obstructive Pulmonary Disease, or COPD) occurs when the walls of the alveoli (air sacs) in the lungs are damaged, becoming less elastic and therefore less able to exchange carbon dioxide for oxygen. LEARN MORE ABOUT... Emphysema National Treatment Trial Evaluation Program Treatment Options ... Education Resources Some alveoli may narrow and collapse while others stretch out of shape and become abnormally large. As a result, the lungs gradually become floppy and overexpanded, making it increasingly difficult for the person to move air in and out of them. Emphysema is usually caused by chronic irritation of the lung tissue, most commonly by cigarette smoke but sometimes by environmental pollutants as well. It can also be caused by an illness such as asthma or tuberculosis, allergy or infection, or an inherited deficiency of a protein called alpha 1-antitrypsin (AAT). People with emphysema typically experience early symptoms such as troubled breathing or shortness of breath while engaging in normal activities like walking, climbing stairs, or doing household chores. If the condition advances without treatment, they may experience:
Maryland Center For The National Emphysema Treatment Trial (NETT)
University, was awarded a National Institutes of Health (NIH) grant to become oneof the 17 centers of excellence in the National emphysema Treatment Trial
http://www.umm.edu/mdnett/

Extractions: National Emphsema Treatment Trial (NETT) In 1997, the University of Maryland, in collaboration with Johns Hopkins University, was awarded a National Institutes of Health (NIH) grant to become one of the 17 centers of excellence in the National Emphysema Treatment Trial (NETT). This national clinical trial is designed to determine what is the best treatment for people with severe emphysema: medical management alone, which typically involves medication and rehabilitation or medical management plus lung volume reduction surgery (LVRS), in which damaged portions of each lung are removed. This surgical treatment has shown promise in recent years by improving lung function and quality of life for many patients. However, there are still questions about whether its long-term benefits actually outweigh those of medical therapy and rehabilitation without surgery. The study, which is funded by the Health Care Financing Administration and managed by the National Heart Lung and Blood Institute, will compare the addition of LVRS to medical therapy in patients with severe emphysema. Each participant will be assigned at random to either a surgical or nonsurgical course of treatment.
Learn About Emphysema From Plainsense
emphysema, a type of Chronic Obstructive Pulmonary Disease (COPD), is a chronic,irreversible but preventable disease. UNDERSTANDING emphysema.
http://www.plainsense.com/Health/Seniors/emphysema.htm

Extractions: Weight Control UNDERSTANDING EMPHYSEMA Emphysema, a type of Chronic Obstructive Pulmonary Disease (COPD), is a chronic, irreversible but preventable disease. It occurs when the tiny air sacs (alveoli) of the lungs are damaged and lose their elasticity. The bronchial tubes become swollen and inflamed and the lungs begin to deflate or spring shut. Emphysema develops gradually over years. The majority of people who have this disease are, or were, smokers. The first symptom of emphysema is usually shortness of breath during exertion. As the disease progresses, the shortness of breath increases and even speaking more than a few words at a time can be difficult. Low oxygen levels, due to the lungs inability to absorb oxygen, can turn lips and fingers blue. The heart becomes burdened trying to maintain circulation, and heart failure is a common result. Each year more than 50,000 people die or are handicapped from emphysema. Unfortunately, emphysema can't be cured, but there are treatments available to help slow the progression of the disease. HOW TO REDUCE YOUR RISK If you smoke, quit now; if you don't, never start.
Member Sign In
Cor Pulmonale With emphysema from Ventricular Electrocardiography J. Willis Hurst,MD. Introduction. Am J Cardiol 16503, 1965.). Cor Pulmonale With emphysema.
http://www.medscape.com/viewarticle/404385
Family Of COPD Support Lists And Programs
emphysema can best be characterized as the progressive destruction of the grapelikesacs that fulfill the lung's basic function exchanging oxygen in the air
http://copd-support.org/

Extractions: Watch Program The List uses LSoft and other methods to distribute e-mail to subscribers of the family of COPD Lists. Presently there are over 2,000 subscribers world wide representing a number of countries and cultures. Frequently referred to as "The List", there really is no single list. Rather, there are a number of lists and programs intended to help meet the needs of individuals afflicted with COPD, caregivers who are responsible for an individual so afflicted, and medical personnel who have a particular interest in pulmonary medicine in general and COPD in particular. The List was established to provide support and education, and as a forum for sharing ideas and solutions in dealing with this affliction. Subscribers are encouraged to participate in the discussion, though they are entitled to just "lurk" if they so choose. The List, and thus this web page, was established to bring together people affected by COPD. It is here to help us communicate with one another; to share ideas and knowledge; to support one another; and to live longer, better quality lives. Chronic Obstructive Pulmonary Disease, or COPD, is a disease that encompasses one or more of the following:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

21-40 of 100 Back | 1 | 2 | 3 | 4 | 5 | Next 20